Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proellex in symptomatic uterine fibroids
NCT00874302Phase 3Withdrawn
- Sponsor
- Repros Therapeutics Inc.
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 3 trial of telapristone in Uterine Fibroids (UF), sponsored by Repros Therapeutics Inc.. Status: withdrawn.
02
Drugs
telapristone
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT00874302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00874302.